{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:55:36Z","timestamp":1766516136275,"version":"3.41.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clinthera.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:25:26Z","timestamp":1748935526000},"page":"546-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Efficacy and Safety of Antibiotic Regimens in Sepsis-Induced Acute Kidney Injury: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"47","author":[{"given":"Yiheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinthera.2025.05.001_bib0001","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/medicina60030434","article-title":"Sepsis-associated acute kidney injury: where are we now?","volume":"60","author":"Kounatidis","year":"2024","journal-title":"Medicina"},{"issue":"6","key":"10.1016\/j.clinthera.2025.05.001_bib0002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ekir.2020.03.005","article-title":"Sepsis-associated acute kidney disease","volume":"5","author":"Peerapornratana","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1016\/j.clinthera.2025.05.001_bib0003","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2174\/138945009789753183","article-title":"Epidemiology of septic acute kidney injury","volume":"10","author":"Parmar","year":"2009","journal-title":"Curr Drug Targets"},{"issue":"4","key":"10.1016\/j.clinthera.2025.05.001_bib0004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jinf.2016.11.013","article-title":"Empirical mono-versus combination antibiotic therapy in adult intensive care patients with severe sepsis\u2013A systematic review with meta-analysis and trial sequential analysis","volume":"74","author":"Sj\u00f6vall","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2025.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2155-1","article-title":"Pharmacokinetics\u2013pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients","volume":"22","author":"Veiga","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.clinthera.2025.05.001_bib0006","first-page":"1","article-title":"Long-term toxicity of fluoroquinolones: a comprehensive review","author":"Hussen","year":"2023","journal-title":"Drug Chem Toxicol"},{"issue":"8","key":"10.1016\/j.clinthera.2025.05.001_bib0007","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/jac\/dkab134","article-title":"Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study","volume":"76","author":"Babich","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2025.05.001_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106512","article-title":"Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: A meta-analysis","volume":"59","author":"Onorato","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.clinthera.2025.05.001_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13054-023-04792-0","article-title":"Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study","volume":"28","author":"Barbier","year":"2024","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.clinthera.2025.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.clinthera.2025.05.001_bib0011","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/08820139.2020.1797778","article-title":"A review of immunomodulatory effects of fluoroquinolones","volume":"50","author":"Assar","year":"2021","journal-title":"Immunol Investig"},{"issue":"4","key":"10.1016\/j.clinthera.2025.05.001_bib0012","first-page":"1","article-title":"Predictive Value of CRP, PCT and ESR on Piperacillin-Tazobactam in Treating Chronic Obstructive Pulmonary Disease with Pneumonia","volume":"69","author":"Xu","year":"2023","journal-title":"Clin Lab"},{"issue":"5","key":"10.1016\/j.clinthera.2025.05.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00084-20","article-title":"Levonadifloxacin, a novel benzoquinolizine fluoroquinolone, modulates lipopolysaccharide-induced inflammatory responses in human whole-blood assay and murine acute lung injury model","volume":"64","author":"Patel","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2025.05.001_bib0014","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s15010-021-01577-x","article-title":"Mono vs. combo regimens with novel beta-lactam\/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature","volume":"49","author":"Meini","year":"2021","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.clinthera.2025.05.001_bib0015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archinte.168.6.609","article-title":"Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction","volume":"168","author":"Newsome","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.clinthera.2025.05.001_bib0016","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.11141113","article-title":"Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI","volume":"9","author":"Prowle","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.clinthera.2025.05.001_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2019.0348","article-title":"When are combinations of antibiotics clinically useful?","volume":"81","author":"York","year":"2020","journal-title":"Br J Hosp Med"},{"issue":"1","key":"10.1016\/j.clinthera.2025.05.001_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkz325","article-title":"Mechanisms of antimicrobial-induced nephrotoxicity in children","volume":"75","author":"Downes","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.clinthera.2025.05.001_bib0019","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","article-title":"Overview of antibiotic-induced nephrotoxicity","volume":"8","author":"Campbell","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1016\/j.clinthera.2025.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/antibiotics11121769","article-title":"Antibiotic therapy in the critically ill with acute renal failure and renal replacement therapy: a narrative review","volume":"11","author":"Corona","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.clinthera.2025.05.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106691","article-title":"Piperacillin\/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis","volume":"61","author":"Su","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.clinthera.2025.05.001_bib0022","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/ijms18071387","article-title":"Issues of acute kidney injury staging and management in sepsis and critical illness: a narrative review","volume":"18","author":"Nusshag","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.clinthera.2025.05.001_bib0023","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"19","key":"10.1016\/j.clinthera.2025.05.001_bib0024","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.3390\/ijms21197115","article-title":"Acute kidney injury in septic patients treated by selected nephrotoxic antibiotic agents\u2014pathophysiology and biomarkers\u2014a review","volume":"21","author":"Petejova","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825001651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825001651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:07:54Z","timestamp":1753880874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825001651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0149291825001651"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.05.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Efficacy and Safety of Antibiotic Regimens in Sepsis-Induced Acute Kidney Injury: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}